Candriam Equities L Biotechnology Class R-H Fonds
222,16
CHF
+4,59
CHF
+2,11
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,35% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,40% |
| Amgen Inc | US0311621009 | 5,32% |
| Gilead Sciences Inc | US3755581036 | 5,09% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,98% |
| BeOne Medicines Ltd ADR | US07725L1026 | 3,32% |
| Insmed Inc | US4576693075 | 3,14% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,81% |
| BioNTech SE ADR | US09075V1026 | 2,71% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,46% |
| Sonstige | 59,42% |